ArticleThe journal of pathology. Clinical research2024

Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.

Ayako Ura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.